PharmAthene Lost Share Value During Pre-Market Trades BioPharma Consumer Cyclicals Diversified Financial Macro Markets Software & ServicesApril 14, 2014 PIP has lost 6.4% during pre-market trading. Sharing Twitter0 Facebook0 Google +0 Linkedinactive){li-icon[type=linkedin-bug][color=inverse] .background{fill Email this article Print this article Tags BARDA, Biomedical Advanced Research, Food and Drug Administration, PharmAthene, PIP, SparVax
